SMARCA2 ligand-13 PYR-Pip-spiro[3.3]heptane-acid
Selected Variant
HY-169490
Size: 1 Each
SMARCA2 ligand-13 PYR-Pip-spiro[3.3]heptane-acid is a conjugate generated by linking a target protein ligand to a linker (HY-169489). SMARCA2 ligand-13 PYR-Pip-spiro[3.3]heptane-acid can be used in the synthesis of PROTACs (e.g. PROTAC SMARCA2 degrader-21 (HY-169272) ).
Product Specifications
UNSPSC
12352005
Target
Target Protein Ligand-Linker Conjugates
Type
Reference compound
Related Pathways
PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/target-protein-ligand-linker-conjugates-4.html
Smiles
O=C(O)C1CC2(CC(C2)N3CCC(CC3)C4=NC(N5CCN6C7=CC(C8=C(C=CC=C8)O)=NN=C7NC[C@H]6C5)=NC=C4)C1
Molecular Formula
C32H38N8O3
Molecular Weight
582.70
References & Citations
[1]Zhang Y, et al., Smarca degraders and uses thereof. WO2023278402. WIPO, 2022-06-28
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
PAX6 (PAX6/1166), CF568 conjugate, 0.1mg/mL
Mucin 1 / EMA / Episialin / CD227 (MUC1/955), CF405S conjugate, 0.1mg/mL
Human Kappa Light Chain (L1C1), CF640R conjugate, 0.1mg/mL
Anti-p73/TP73 Antibody Picoband® (FITC Conjugate)
Anti-PIANP Antibody Picoband®, FITC Conjugate
